Literature DB >> 646467

Detection of immune complexes in serum of patients with ankylosing spondylitis.

V Corrigall, G S Panayi, A Unger, R N Poston, B D Williams.   

Abstract

Immune complexes were measured in the sera of 18 patients iwth ankylosing spondylitis and 5 normal control subjects by their ability to inhibit antibody-mediated lymphocyte-induced cytotoxicity. 11 of the spondylitis and none of the control sera contained circulating complexes. Fractionation of sera on Sephadex G-200 showed that complexes were of two molecular sizes, one of intermediate and the other of large molecular weight. The presence of immune complexes did not correlate with activity of disease or the presence of peripheral arthritis although the one patient with polyarthritis had the highest level of complexes detected in this study. The nature of the antigen in these antigen-antibody complexes is of great interest since it may provide evidence of the aetiological agent in the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646467      PMCID: PMC1001182          DOI: 10.1136/ard.37.2.159

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Lymphocyte response to IgG in patients with ankylosing spondylitis and their families.

Authors:  R H Weisbart; R I Morris; P I Terasaki; R Bluestone; L S Goldberg
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

Authors:  T D Kinsella; L Espinoza; F B Vasey
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

3.  Antibody-mediated leucocyte cytotoxicity to Chang human liver cells in rheumatoid arthritis and other diseases.

Authors:  G S Panayi
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

4.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

5.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

6.  Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments.

Authors:  F Wisloff; T E Michaelsen; S S Froland
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

7.  Aggregation of human immunoglobulin G upon freezing.

Authors:  U B Hansson
Journal:  Acta Chem Scand       Date:  1968

8.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

9.  Antiglobulins in ankylosing spondylitis.

Authors:  R M Arana; M T de la Vega; A Porrini; O Garcia Morteo
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

10.  The molecular basis of self-association of IgG-Rheumatoid factors.

Authors:  R M Pope; D C Teller; M Mannik
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

  10 in total
  11 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Authors:  J N Rosenberg; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

3.  Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.

Authors:  R N Poston; R S Morgan
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

4.  Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.

Authors:  B Duquesnoy; F Santoro; P Wattre; B Delcambre
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

5.  The in-vivo metabolism of C3 in ankylosing spondylitis.

Authors:  L Brinch; O Vinje; P Teisberg; O J Mellbye; I Aakesson
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

6.  The absence of circulating immune complexes in patients with ankylosing spondylitis.

Authors:  W Maksymowych; M K Dasgupta; R S Rothwell; J B Dossetor; A S Russell
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

7.  Circulating immune complexes in patients with ankylosing spondylitis.

Authors:  G S Panayi; J Slaney; B D Williams
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

8.  Yersinia arthritis: a clinical, immunological, and family study of 2 cases.

Authors:  P J Sheldon; N S Mair; E Fox
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

9.  The relationship between genetics and environment in the pathogenesis of rheumatic diseases.

Authors:  A Calin
Journal:  West J Med       Date:  1979-09

10.  Clinical study of Thai patients with ankylosing spondylitis.

Authors:  U Deesomchok; T Tumrasvin
Journal:  Clin Rheumatol       Date:  1985-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.